Down-regulation of BTG1 by MiR-454-3p Enhances Cellular Radiosensitivity in Renal Carcinoma Cells

Overview

Journal Radiat Oncol

Publisher Biomed Central

Specialties Oncology
Radiology

Date 2014 Aug 14

PMID 25115181

Citations 26

Authors

Xin Wu

Nan Ding

Wentao Hu

Jinpeng He

Shuai Xu

Hailong Pei

Junrui Hua

Guangming Zhou

JuFang Wang

Affiliations

Soon will be listed here.

Abstract

Background: B cell translocation gene 1 (BTG1) has long been recognized as a tumor suppressor gene. Recent reports demonstrated that BTG1 plays an important role in progression of cell cycle and is involved in cellular response to stressors. However, the microRNAs mediated regulatory mechanism of BTG1 expression has not been reported so far. MicroRNAs can effectively influence tumor radiosensitivity by preventing cell cycle progression, resulting in enhancement of the cytotoxicity of radiotherapy efficacy. This study aimed to demonstrating the effects of microRNAs on the BTG1 expression and cellular radiosensitivity.

Methods: The human renal carcinoma 786-O cells were treated with 5 Gy of X-rays. Expressions of BTG1 gene and miR-454-3p, which was predicted to target BTG1 by software algorithm, were analyzed by quantitative polymerase chain reaction. Protein expressions were assessed by Western blot. Luciferase assays were used to quantify the interaction between BTG1 3'-untranslated region (3'-UTR) and miR-454-3p. The radiosensitivity was quantified by the assay of cell viability, colony formation and caspase-3 activity.

Results: The expression of the BTG1 gene in 786-O cells was significantly elevated after treatments with X-ray irradiation, DMSO, or serum starvation. The up-regulation of BTG1 after irradiation reduced cellular radiosensitivity as demonstrated by the enhanced cell viability and colony formation, as well as the repressed caspase-3 activity. In comparison, knock down of BTG1 by siRNA led to significantly enhanced cellular radiosensitivity. It was found that miR-454-3p can regulate the expression of BTG1 through a direct interaction with the 3'-UTR of BTG1 mRNA. Decreasing of its expression level correlates well with BTG1 up-regulation during X-ray irradiation. Particularly, we observed that over-expression of miR-454-3p by transfection inhibited the BTG1 expression and enhanced the radiosensitivity. In addition, cell cycle analysis showed that over-expression of miR-454-3p shifted the cell cycle arrest from G2/M phase to S phase.

Conclusions: Our results indicate that BTG1 is a direct target of miR-454-3p. Down-regulation of BTG1 by miR-454-3p renders tumor cells sensitive to radiation. These results may shed light on the potential application in tumor radiotherapy.

Citing Articles

Exploring of miR-155-5p, miR-181b-5p, and miR-454-3p Expressions in Circulating Cell-Free RNA: Insights from Peripheral Blood of Uveal Malignant Melanoma Patients.

Masoumeh H, Tunay D, Demet O, Samuray T, Hulya Y Biochem Genet. 2024; .

PMID: 38914847 DOI: 10.1007/s10528-024-10849-8.

HAGLR, A Long Non-coding RNA of Potential Tumor Suppressive Function in Clear Cell Renal Cell Carcinoma: Diagnostic and Prognostic Implications.

Bardhan A, Banerjee A, Pal D, Ghosh A Mol Biotechnol. 2023; 66(12):3485-3497.

PMID: 37955777 DOI: 10.1007/s12033-023-00948-z.

Analysis of the Applicability of microRNAs in Peripheral Blood Leukocytes as Biomarkers of Sensitivity and Exposure to Fractionated Radiotherapy towards Breast Cancer.

Marczyk M, Polanska J, Wojcik A, Lundholm L Int J Mol Sci. 2021; 22(16).

PMID: 34445424 PMC: 8395710. DOI: 10.3390/ijms22168705.

LncRNA MEG8 promotes TNF-α expression by sponging miR-454-3p in bone-invasive pituitary adenomas.

Zhu H, Li B, Guo J, Miao Y, Shen Y, Zhang Y Aging (Albany NY). 2021; 13(10):14342-14354.

PMID: 34016788 PMC: 8202870. DOI: 10.18632/aging.203048.

Downregulation of high mobility group box 1 enhances the radiosensitivity of non-small cell lung cancer by acting as a crucial target of microRNA-107.

Bai L, Zhang J, Gao D, Liu C, Li W, Li Q Exp Ther Med. 2021; 22(1):679.

PMID: 33986844 PMC: 8112155. DOI: 10.3892/etm.2021.10111.

References

Suk K, Sipes D, Erickson K . Enhancement of B-cell translocation gene-1 expression by prostaglandin E2 in macrophages and the relationship to proliferation. Immunology. 1997; 91(1):121-9. PMC: 1364044. DOI: 10.1046/j.1365-2567.1997.00235.x. View

Rouault J, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L . BTG1, a member of a new family of antiproliferative genes. EMBO J. 1992; 11(4):1663-70. PMC: 556617. DOI: 10.1002/j.1460-2075.1992.tb05213.x. View

Yang X, Feng M, Jiang X, Wu Z, Li Z, Aau M . miR-449a and miR-449b are direct transcriptional targets of E2F1 and negatively regulate pRb-E2F1 activity through a feedback loop by targeting CDK6 and CDC25A. Genes Dev. 2009; 23(20):2388-93. PMC: 2764491. DOI: 10.1101/gad.1819009. View

Ye C, Zhang X, Wan J, Chang L, Hu W, Bing Z . Radiation-induced cellular senescence results from a slippage of long-term G2 arrested cells into G1 phase. Cell Cycle. 2013; 12(9):1424-32. PMC: 3674070. DOI: 10.4161/cc.24528. View

Shi L, Chen J, Yang J, Pan T, Zhang S, Wang Z . MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Brain Res. 2010; 1352:255-64. DOI: 10.1016/j.brainres.2010.07.009. View

Hanisch A, Sillje H, Nigg E . Timely anaphase onset requires a novel spindle and kinetochore complex comprising Ska1 and Ska2. EMBO J. 2006; 25(23):5504-15. PMC: 1679759. DOI: 10.1038/sj.emboj.7601426. View

Hu W, Chan C, Wu R, Zhang C, Sun Y, Song J . Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol Cell. 2010; 38(5):689-99. PMC: 2900922. DOI: 10.1016/j.molcel.2010.05.027. View

Lu Z, Li Y, Takwi A, Li B, Zhang J, Conklin D . miR-301a as an NF-κB activator in pancreatic cancer cells. EMBO J. 2010; 30(1):57-67. PMC: 3020116. DOI: 10.1038/emboj.2010.296. View

Zhao L, Chen X, Cao Y . New role of microRNA: carcinogenesis and clinical application in cancer. Acta Biochim Biophys Sin (Shanghai). 2011; 43(11):831-9. DOI: 10.1093/abbs/gmr080. View

10.

Yang J, Li J, Shao P, Zhou H, Chen Y, Qu L . starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res. 2010; 39(Database issue):D202-9. PMC: 3013664. DOI: 10.1093/nar/gkq1056. View

11.

Carlson C, Ethier S . Lack of RB protein correlates with increased sensitivity to UV-radiation-induced apoptosis in human breast cancer cells. Radiat Res. 2000; 154(5):590-9. DOI: 10.1667/0033-7587(2000)154[0590:lorpcw]2.0.co;2. View

12.

Jalava S, Urbanucci A, Latonen L, Waltering K, Sahu B, Janne O . Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer. Oncogene. 2012; 31(41):4460-71. DOI: 10.1038/onc.2011.624. View

13.

Cho I, Lee A, Lee S, Lee M, Kim S . Repression by oxidative stress of iNOS and cytokine gene induction in macrophages results from AP-1 and NF-kappaB inhibition mediated by B cell translocation gene-1 activation. Free Radic Biol Med. 2005; 39(11):1523-36. DOI: 10.1016/j.freeradbiomed.2005.07.017. View

14.

Das E, Jana N, Bhattacharyya N . MicroRNA-124 targets CCNA2 and regulates cell cycle in STHdh(Q111)/Hdh(Q111) cells. Biochem Biophys Res Commun. 2013; 437(2):217-24. DOI: 10.1016/j.bbrc.2013.06.041. View

15.

Servomaa K, Kiuru A, Grenman R . Increased radiosensitivity is associated with p53 mutations in cell lines derived from oral cavity carcinoma. Acta Otolaryngol. 1996; 116(2):341-4. DOI: 10.3109/00016489609137854. View

16.

Kasinski A, Slack F . Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 2011; 11(12):849-64. PMC: 4314215. DOI: 10.1038/nrc3166. View

17.

Lin W, Gary J, Yang M, Clarke S, Herschman H . The mammalian immediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem. 1996; 271(25):15034-44. DOI: 10.1074/jbc.271.25.15034. View

18.

Hata K, Nishijima K, Mizuguchi J . Role for Btg1 and Btg2 in growth arrest of WEHI-231 cells through arginine methylation following membrane immunoglobulin engagement. Exp Cell Res. 2007; 313(11):2356-66. DOI: 10.1016/j.yexcr.2007.03.021. View

19.

Huerta S, Gao X, Dineen S, Kapur P, Saha D, Meyer J . Role of p53, Bax, p21, and DNA-PKcs in radiation sensitivity of HCT-116 cells and xenografts. Surgery. 2013; 154(2):143-51. DOI: 10.1016/j.surg.2013.03.012. View

20.

Kobayashi T, Ishida J, Musashi M, Ota S, Yoshida T, Shimizu Y . p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5. Int J Cancer. 2010; 128(2):304-18. DOI: 10.1002/ijc.25345. View